Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 70, Issue 1, 2011, Pages 235-236

  Roescher, N ^a,b   Kingman, A ^a   Shirota, Y ^a   Chiorini, J A ^a   Illei, G G ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MUSCARINIC M3 RECEPTOR; PEPTIDE DERIVATIVE;

ANTIBODY DETECTION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME;

AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; RECEPTOR, MUSCARINIC M3; SENSITIVITY AND SPECIFICITY; SJOGREN'S SYNDROME;

EID: 78650672592     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.129049     Document Type: Article

References (11)

1. Dawson L, Tobin A, Smith P, et al. Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going? Arthritis Rheum 2005;52:2984-95.
2. Naito Y, Matsumoto I, Wakamatsu E, et al. Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome. Ann Rheum Dis 2005;64:510-11.
3. Kovács L, Marczinovits I, György A, et al. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome. Rheumatology (Oxford) 2005;44:1021-5. (Pubitemid 41487176)
4. Cavill D, Waterman SA, Gordon TP. Failure to detect antibodies to extracellular loop peptides of the muscarinic M3 receptor in primary Sjögren's syndrome. J Rheumatol 2002;29:1342-4.
5. Zigon P, Bozic B, Cucnik S, et al. Are autoantibodies against a 25-mer synthetic peptide of M3 muscarinic acetylcholine receptor a new diagnostic marker for Sjögren's syndrome? Ann Rheum Dis 2005;64:1247; author reply 1247.
6. Nakamura Y, Wakamatsu E, Matsumoto I, et al. High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile-onset Sjögren syndrome. Ann Rheum Dis 2008;67:136-7.
7. Schellekens GA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-63.
8. Tam JP, Zavala F. Multiple antigen peptide. A novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays. J Immunol Methods: 1989;124:53-61.
9. Vitali C, Bombardieri S, Jonsson R, et al.; European Study Group on Classification Criteria for Sjögren's Syndrome. Classifi cation criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
10. Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 2000;43:1647-54.
11. Dawson LJ, Stanbury J, Venn N, et al. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 2006;54:1165-73.